MELD and prediction of post-liver transplantation survival.

PubWeight™: 1.33‹?› | Rank: Top 10%

🔗 View Article (PMID 16498643)

Published in Liver Transpl on March 01, 2006

Authors

Shahid Habib1, Brian Berk, Chung-Chou H Chang, Anthony J Demetris, Paulo Fontes, Igor Dvorchik, Bijan Eghtesad, Amadeo Marcos, A Obaid Shakil

Author Affiliations

1: Division of Gastroenterology, Hepatology & Nutrition, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.

Associated clinical trials:

Prediction of Mortality in Patients Waiting for Liver Transplantation Through Brain Magnetic Resonance Imaging | NCT01434056

Equity and Efficacy of Allocation Priority for Liver Transplantation Patients With MELD≥30 in Italy | NCT04530240

Articles citing this

Geographic inequity in access to livers for transplantation. Transplantation (2011) 1.71

Epidemiology and risk factors for bacteremia in 144 consecutive living-donor liver transplant recipients. Yonsei Med J (2009) 1.04

Pre-operative risk factors predict post-operative respiratory failure after liver transplantation. PLoS One (2011) 1.00

Experience Since MELD Implementation: How Does the New System Deliver? Int J Hepatol (2012) 0.92

Diabetes mellitus increases the risk of mortality following liver transplantation independent of MELD score. Dig Dis Sci (2010) 0.92

Model for end-stage liver disease versus the Child-Pugh score in predicting the post-transplant 3-month and 1-year mortality in a cohort of Chinese recipients. Surg Today (2009) 0.87

Outcome of using small-for-size grafts in living donor liver transplantation recipients with high model for end-stage liver disease scores: a single center experience. PLoS One (2013) 0.82

COMPARATIVE STUDY ON LIVER TRANSPLANTATION WITH AND WITHOUT HEPATOCELLULAR CARCINOMA WITH CIRRHOSIS: ANALYSIS OF MELD, WAITING TIME AND SURVIVAL. Arq Bras Cir Dig (2016) 0.82

Model for End-Stage Liver Disease, Model for Liver Transplantation Survival and Donor Risk Index as predictive models of survival after liver transplantation in 1,006 patients. Clinics (Sao Paulo) (2015) 0.81

Outcomes among older adult liver transplantation recipients in the model of end stage liver disease (MELD) era. Ann Transplant (2014) 0.80

Adult Living Donor Liver Transplantation for Acute-on-Chronic Liver Failure in High- Model for End-Stage Liver Disease Score Patients. Am J Transplant (2017) 0.80

Adult-to-adult living donor liver transplantation for acute liver failure in China. World J Gastroenterol (2012) 0.79

The MELD score predicts the short-term and overall survival after liver transplantation in patients with primary sclerosing cholangitis or autoimmune liver diseases. Langenbecks Arch Surg (2014) 0.77

Report of depressive symptoms on waiting list and mortality after liver and kidney transplantation: a prospective cohort study. BMC Psychiatry (2011) 0.77

Low serum factor V level: early predictor of allograft failure and death following liver transplantation. Langenbecks Arch Surg (2015) 0.76

Can living donor liver transplantation offer similar outcomes to deceased donor liver transplantation using expanded selection criteria for hepatocellular carcinoma? Pak J Med Sci (2015) 0.76

Evaluation of Malnutrition Risk after Liver Transplantation Using the Nutritional Screening Tools. Clin Nutr Res (2015) 0.75

The Current State of Liver Transplantation. Gastroenterol Hepatol (N Y) (2006) 0.75

Organ Transplantation in the Face of Donor Shortage - Ethical Implications with a Focus on Liver Allocation. Visc Med (2016) 0.75

Intercontinental comparison of patient cohorts: what can we learn from it? Gut (2007) 0.75

Clinical impact of preoperative brain MR angiography and MR imaging in candidates for liver transplantation: a propensity score-matching study in a single institution. Eur Radiol (2017) 0.75

Articles by these authors

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med (2002) 11.38

Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology (2005) 10.66

Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology (2004) 6.98

A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med (2006) 6.31

HIV infection and the risk of acute myocardial infarction. JAMA Intern Med (2013) 5.90

Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant (2005) 5.87

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant (2003) 4.54

Tolerogenic immunosuppression for organ transplantation. Lancet (2003) 4.09

Production of alpha 1,3-galactosyltransferase-deficient pigs. Science (2002) 3.96

Measurement of serum acetaminophen-protein adducts in patients with acute liver failure. Gastroenterology (2006) 3.85

Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology (2007) 3.18

Liver organ allocation for hepatocellular carcinoma: are we sure? Liver Transpl (2003) 3.11

Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl (2005) 2.63

Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort. Am J Respir Crit Care Med (2010) 2.60

Depressive symptoms and cognitive decline in late life: a prospective epidemiological study. Arch Gen Psychiatry (2006) 2.41

Estimating the proportion of patients infected with HIV who will die of comorbid diseases. Am J Med (2005) 2.38

One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Liver Transpl (2002) 2.38

Is survival better at hospitals with higher "end-of-life" treatment intensity? Med Care (2010) 2.35

Liver transplantation for hepatocellular carcinoma: extension of indications based on molecular markers. J Hepatol (2008) 2.22

Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia. Clin Infect Dis (2003) 2.19

Considerations in the statistical analysis of hemodialysis patient survival. J Am Soc Nephrol (2009) 2.18

The impact of postreperfusion syndrome on short-term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation. Liver Transpl (2008) 2.11

A higher sense of purpose in life is associated with sexual enjoyment in midlife women. Menopause (2011) 2.09

Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology (2006) 2.08

A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C. Liver Transpl (2002) 2.07

Influence of race on inpatient treatment intensity at the end of life. J Gen Intern Med (2007) 2.07

Muscle mass predicts outcomes following liver transplantation. Liver Transpl (2013) 2.04

Safety and efficacy of splenic artery embolization for portal hyperperfusion in liver transplant recipients: a 5-year experience. Liver Transpl (2015) 2.03

Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease. Liver Transpl (2006) 2.02

Role of baseline echocardiography in the preoperative management of liver transplant candidates. Am J Cardiol (2012) 1.98

Near-total human face transplantation for a severely disfigured patient in the USA. Lancet (2009) 1.97

Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. J Am Coll Surg (2005) 1.93

Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. Clin Infect Dis (2003) 1.89

Should we biopsy each liver mass suspicious for hepatocellular carcinoma before liver transplantation?--yes. J Hepatol (2005) 1.89

Outcomes of mild cognitive impairment by definition: a population study. Arch Neurol (2011) 1.84

Treatment of hepatic epithelioid hemangioendothelioma: a single-institution experience with 25 cases. Arch Surg (2009) 1.82

Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease. Liver Transpl (2005) 1.79

Racial variation in end-of-life intensive care use: a race or hospital effect? Health Serv Res (2006) 1.76

Evidence for hyperacute rejection of human liver grafts: The case of the canary kidneys. Clin Transplant (1989) 1.74

First U.S. near-total human face transplantation: a paradigm shift for massive complex injuries. Plast Reconstr Surg (2010) 1.70

Home screening for sexually transmitted diseases in high-risk young women: randomised controlled trial. Sex Transm Infect (2007) 1.70

Successful treatment of small-for-size syndrome in adult-to-adult living-related liver transplantation: single center series. Clin Transplant (2007) 1.70

Outcomes after out-of-hospital endotracheal intubation errors. Resuscitation (2008) 1.69

Posttransplant biliary complications in the pre- and post-model for end-stage liver disease era. Liver Transpl (2011) 1.63

Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody. Transplantation (2008) 1.62

The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C. Circ Cardiovasc Qual Outcomes (2011) 1.62

Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles. Liver Transpl (2005) 1.61

A repertoire-independent and cell-intrinsic defect in murine GVHD induction by effector memory T cells. Blood (2011) 1.60

Gc-globulin and prognosis in acute liver failure. Liver Transpl (2005) 1.59

Development and validation of hospital "end-of-life" treatment intensity measures. Med Care (2009) 1.58

Hypophosphatemia after 95 right-lobe living-donor hepatectomies for liver transplantation is not a significant source of morbidity. Transplantation (2003) 1.57

Alcohol and drug use and related disorders: An underrecognized health issue among adolescents and young adults attending sexually transmitted disease clinics. Sex Transm Dis (2006) 1.57

Memory T cells from minor histocompatibility antigen-vaccinated and virus-immune donors improve GVL and immune reconstitution. Blood (2011) 1.55

Predictive value of actin-free Gc-globulin in acute liver failure. Liver Transpl (2007) 1.55

Comorbid medical and psychiatric conditions and substance abuse in HCV infected persons on dialysis. J Hepatol (2006) 1.54

ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions. Hepatology (2002) 1.54

Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg (2003) 1.52

How much do depressive symptoms affect cognition at the population level? The Monongahela-Youghiogheny Healthy Aging Team (MYHAT) study. Int J Geriatr Psychiatry (2009) 1.52

Side-to-side cavocavostomy with an endovascular stapler: Rescue technique for severe hepatic vein and/or inferior vena cava outflow obstruction after liver transplantation using the piggyback technique. Liver Transpl (2009) 1.51

Long-term HIV/AIDS survival estimation in the highly active antiretroviral therapy era. Med Decis Making (2003) 1.49

Enhancing alloreactivity does not restore GVHD induction but augments skin graft rejection by CD4⁺ effector memory T cells. Eur J Immunol (2011) 1.49

Safety and effectiveness of renoportal bypass in patients with complete portal vein thrombosis: an analysis of 10 patients. Liver Transpl (2015) 1.49

Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant (2006) 1.48

Terminal decline and practice effects in older adults without dementia: the MoVIES project. Neurology (2011) 1.46

Prevalence of mild cognitive impairment by multiple classifications: The Monongahela-Youghiogheny Healthy Aging Team (MYHAT) project. Am J Geriatr Psychiatry (2010) 1.45

Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation (2004) 1.43

Transplantation of en bloc pediatric kidneys when the proximal vascular cuff is too short. Transplantation (2007) 1.42

Three-dimensional print of a liver for preoperative planning in living donor liver transplantation. Liver Transpl (2013) 1.39

A cluster randomized trial of a multifaceted quality improvement intervention in Brazilian intensive care units: study protocol. Implement Sci (2015) 1.38

Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation. J Pediatr (2006) 1.36

Age and education effects and norms on a cognitive test battery from a population-based cohort: the Monongahela-Youghiogheny Healthy Aging Team. Aging Ment Health (2010) 1.34

Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. JAMA (2012) 1.33

Fulminant hepatic failure. Liver Transpl (2005) 1.32

Differential effects of out-of-hospital interventions on short- and long-term survival after cardiopulmonary arrest. Resuscitation (2005) 1.32

Pathways to injury in chronic pancreatitis: decoding the role of the high-risk SPINK1 N34S haplotype using meta-analysis. PLoS One (2008) 1.32

Expression of specific hepatocyte and cholangiocyte transcription factors in human liver disease and embryonic development. Lab Invest (2008) 1.32

Adult living donor versus deceased donor liver transplantation: a 6-year single center experience. Am J Transplant (2005) 1.31

Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg (2013) 1.30

Racial differences in adherence to cardiac medications. J Natl Med Assoc (2003) 1.28

Viral hepatitis-related acute liver failure. Am J Gastroenterol (2003) 1.28

Wnt'er in liver: expression of Wnt and frizzled genes in mouse. Hepatology (2007) 1.27

Effects of donor T-cell trafficking and priming site on graft-versus-host disease induction by naive and memory phenotype CD4 T cells. Blood (2008) 1.27

Estimating the rate of accumulating drug resistance mutations in the HIV genome. Value Health (2007) 1.26

Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysis. Eur J Cancer (2012) 1.26

Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology (2006) 1.24

Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody. Clin Infect Dis (2006) 1.23

Physical activity, health status and risk of hospitalization in patients with severe chronic obstructive pulmonary disease. Respiration (2010) 1.22

Porcine partial liver transplantation: a novel model of the "small-for-size" liver graft. Liver Transpl (2004) 1.22

Posttransplant metabolic syndrome: an epidemic waiting to happen. Liver Transpl (2009) 1.22